Skip to main content
Clinical Trials/NCT01124825
NCT01124825
Withdrawn
Phase 4

Use of New Supraglottic Airway Devices in Severely Obese Patients: A Feasibility Study

University of Louisville1 site in 1 countryJuly 2011
ConditionsObesity

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Louisville
Locations
1
Primary Endpoint
Airway Sealing Pressure
Status
Withdrawn
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine whether two new airway devices used during anesthesia called iGEL™ and KING-LTS-DTM work well and are safe in obese patients. They both work well in thin patients, but have not been tested in obese patients.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
October 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Scheduled for elective surgery with an estimated duration of 30 to 120 minutes
  • American Society of Anesthesiologists (ASA) status I-III
  • Aged 18 to 65 years.
  • Body mass index (BMI) ≥ 35 kg/m2

Exclusion Criteria

  • A history of difficult intubation;
  • Immobilized cervical spine;
  • Oxygen saturation less than 95% at room air;
  • A history of uncontrolled gastroesophageal reflux or hiatus hernia;
  • A history of ulcer surgery including vagotomy;
  • Previous gastric bypass surgery;
  • Diabetic gastroparesis;
  • Patients with known coagulation disorders (e.g. hemophilias, von Willebrand disease, factor V leiden diseases) or on systemic anticoagulation drugs (e.g. continuous heparin infusion); Patients with abnormal coagulation tests will be also excluded. However, asymptomatic patients will not be tested on any coagulation disorders.
  • Any pathologies of the mouth, pharynx or larynx, the access to the airway is restricted, or a difficult tracheal intubation is anticipated.
  • Pregnant or breast-feeding (pregnancy status will be confirmed by a pregnancy test, as it is standard for all surgical procedures at the University hospital).

Outcomes

Primary Outcomes

Airway Sealing Pressure

Time Frame: 1-3 hours

Oropharyngeal leak pressure in cm H2O for the duration of the case at 1, 15, 30, 60, 120 minutes.

Secondary Outcomes

  • Difference in insertion time for one of the supraglottic airway devices(1-3 hours)

Study Sites (1)

Loading locations...

Similar Trials